The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D005971:Glutamates / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects*; D006892:Hydroxydopamines / Q000494:pharmacology; D007478:Iontophoresis; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D014439:Tyramine / Q000494:pharmacology
D000605:Amino Alcohols; D000613:Aminobutyrates; D000813:Anilides; D005971:Glutamates; D006892:Hydroxydopamines; D011453:Prostaglandins; D000628:Aminophylline; D012701:Serotonin; D003983:Dibenzylchlorethamine; D003994:Bucladesine; D000255:Adenosine Triphosphate; D011433:Propranolol; D010208:Papaverine; D000242:Cyclic AMP; D000109:Acetylcholine; D003891:Desipramine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D010646:Phentolamine